share_log

Stifel Maintains Buy on HilleVax, Lowers Price Target to $30

Benzinga ·  Nov 10, 2023 15:26

Stifel analyst Stephen Willey maintains HilleVax (NASDAQ:HLVX) with a Buy and lowers the price target from $35 to $30.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment